Share this

News RSS

Contact Us

Media Contacts:

Randy Buckwalter Public Relations Manager
PPD
Tel: +1 919 456 4425

Lee Kennedy Corporate Communications Manager
PPD
Tel: +1 919 456 5350

16 Dec. 2014

PPD and ERT Establish Strategic Partnership to Enhance Drug Development

PPD and ERT today announced a strategic partnership to facilitate delivery of ERT’s comprehensive solutions for patient safety and efficacy endpoint data collection to help biopharmaceutical clients conduct clinical trials in a more efficient and cost-effective manner.

18 Nov. 2014

PPD's Randy Anderson Named Health Care Hero for Diabetes Research

PPD today announced that Randy Anderson, Ph.D., vice president of global product development and therapeutic area leader for metabolics, was named a 2014 Health Care Hero. The annual awards honor members of the greater Wilmington medical community for their engagement on critical health issues.

10 Nov. 2014

PPD Recognized for Innovative Employee Benefits Programs

PPD today announced it has been named to the 2014 Best Adoption-Friendly Workplaces List by the Dave Thomas Foundation for Adoption.

24 Oct. 2014

PPD Renews Commitment to PPD Beach2Battleship Triathlon

PPD today announced it has renewed its commitment as title sponsor of the annual PPD Beach2Battleship Triathlon. PPD has supported the annual iron-distance triathlon – scheduled for Saturday, Oct. 25 – as the title sponsor since 2010.

25 Sept. 2014

PPD Exercises Option to Acquire Remaining Interest in X-Chem, Inc.

PPD and X-Chem, Inc. announced today that PPD has exercised its option to acquire the remaining minority ownership interest of X-Chem, Inc. X-Chem will continue to operate as a biotechnology company with its entire existing staff.

04 Sept. 2014

PPD Beach2Battleship Heroes Promote Participation in Clinical Trials

PPD today announced the 2014 PPD Heroes team of athletes competing in the Oct. 25 PPD Beach2Battleship Triathlon, one of the top-rated iron distance events in the world. 

03 Sept. 2014

PPD Acquires RCT Logic’s Exclusive License to Patented Clinical Trial Design Technology

PPD announced today that it has acquired RCT Logic’s exclusive license from Massachusetts General Hospital (MGH) for the portfolio of patents related to its sequential parallel comparison design (SPCD). SPCD is an alternative method for conducting well-controlled clinical trials that substantially decreases the impact on trial outcomes of any placebo effect and will enable PPD’s clients to significantly reduce the time and cost of conducting their clinical trials. 

25 Aug. 2014

Robert Hureau Joins PPD as Executive Vice President and Chief Financial Officer

PPD today announced the appointment of Robert Hureau as executive vice president and chief financial officer. 

28 Jul. 2014

PPD Adds Customer-Focused Strategic Leader to Drive Client Success

PPD today announced the appointment of Henry Levy as executive vice president of client development and commercial services. 

09 Jul. 2014

PPD Honored for Communications Promoting the Value of Clinical Trials

PPD announced the company has been recognized with awards for excellence in multimedia and digital communications that demonstrate the importance of clinical research in developing life-changing medical treatments. PPD recently earned four Telly Awards and three Web Health Awards.

Connect With Us

We want to hear from you. 

Investigators Needed

Register in PPD’s database.  

Stay Connected

RSS LinkedIn
Contact Site Map Legal Notices Privacy Policy

© 2014 Pharmaceutical Product Development, LLC. All rights reserved.

Google+